Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410133 | SCV000485377 | likely pathogenic | Neuronal ceroid lipofuscinosis 2 | 2015-11-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001390448 | SCV001592187 | pathogenic | not provided | 2022-07-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370140). This premature translational stop signal has been observed in individual(s) with neuronal ceroid lipofuscinoses (PMID: 30541466). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Ile484Aspfs*7) in the TPP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TPP1 are known to be pathogenic (PMID: 10330339). |
Foundation for Research in Genetics and Endocrinology, |
RCV000410133 | SCV000803212 | likely pathogenic | Neuronal ceroid lipofuscinosis 2 | 2016-03-16 | no assertion criteria provided | clinical testing | The observed variant NM_000391.3:c.1449_1450insG (p.Ile484AspfsTer7) was neither found in 1000 Genomes nor in ExAC databases. The in silico prediction of the given variant is disease causing by MutationTaster2. The above mentioned variant was identified as compound heterozygous along with another variant NM_000391.3:c.689_689delT (p.Phe230SerfsTer28). The variant c.689_689delT (p.Phe230SerfsTer28) was neither found in 1000 Genomes nor in ExAC databases. The in silico prediction of the given variant is disease causing by MutationTaster2. |